Ontology highlight
ABSTRACT: Background
The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC] plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) is unclear.Purpose
To examine the effects of dual versus triple therapy on bleeding and ischemic outcomes in adults with AF after PCI.Data sources
Searches of PubMed, EMBASE, and the Cochrane Library (inception to 31 December 2019) and ClinicalTrials.gov (7 January 2020) without language restrictions; journal Web sites; and reference lists.Study selection
Randomized controlled trials that compared the effects of dual versus triple therapy on bleeding, mortality, and ischem
SUBMITTER: Khan SU
PROVIDER: S-EPMC7489449 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature